Status:

RECRUITING

Registry of Ehlers-Danlos Syndrome

Lead Sponsor:

Luca Sangiorgi

Conditions:

Ehlers-Danlos Syndrome

Eligibility:

All Genders

Brief Summary

RED is a retrospective and prospective registry, finalized for care and research purposes. It is articulated in main sections - strongly related and mutually dependent on each other - corresponding to...

Detailed Description

The traditional method of collecting patient information is often chaotic, inconvenient and sometimes even unsafe, particularly when dealing with rare diseases. In 2014, the need to simplify the diagn...

Eligibility Criteria

Inclusion

  • All Ehlers-Danlos Syndrome patients, including prenatal and fetal diagnosis of Ehlers-Danlos Syndrome

Exclusion

  • Any condition unrelated to Ehlers-Danlos Syndrome

Key Trial Info

Start Date :

June 1 2014

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

January 1 2033

Estimated Enrollment :

3000 Patients enrolled

Trial Details

Trial ID

NCT04133272

Start Date

June 1 2014

End Date

January 1 2033

Last Update

November 20 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Irccs Istituto Ortopedico Rizzoli

Bologna, Emilia-Romagna, Italy, 40136